---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-131322"
form_type: "8-K"
ticker: "MRKR"
cik: "0001094038"
company_name: "Marker Therapeutics, Inc."
filed_at: "2024-12-23T23:59:59+00:00"
generated_at: "2026-05-28T23:29:57.907964+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Marker Therapeutics closes $16.1M private placement of stock and warrants

## Summary
- Gross proceeds ~$16.1M from sale of 1,783,805 shares, Series A warrants (5,031,250 shares at $4.00/sh), and pre-funded warrants (3,248,445 shares at $0.001/sh).
- Closed December 23, 2024; net proceeds for general corporate purposes and working capital.
- Company must seek stockholder approval for warrant share issuance within 90 days; ~27% of stockholders agreed to vote in favor.
- Registration rights agreement requires resale registration statement filed by January 14, 2025.

## SEC filing metadata
- accession: 0001104659-24-131322
- form_type: 8-K
- ticker: MRKR
- cik: 0001094038
- company_name: Marker Therapeutics, Inc.
- filed_at: 2024-12-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1094038/000110465924131322/0001104659-24-131322-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1094038/000110465924131322/tm2431905d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-131322
- JSON: https://secwatch.observer/filing/0001104659-24-131322.json
- Plain text: https://secwatch.observer/filing/0001104659-24-131322.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.